AbbVie | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
AbbVie | SD: Specialized disclosure report
AbbVie | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
AbbVie | 8-K/A: Poll Results of AbbVie Meeting (Amendment)
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Davis Jennifer L.
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Quaggin Susan E
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director RAPP EDWARD J
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director FREYMAN THOMAS C
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Hart Brett J
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director MEYER MELODY B
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Roberts Rebecca B
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director BURNSIDE WILLIAM H.L.
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director TILTON GLENN F
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director WADDELL FREDERICK H
AbbVie | 10-Q: Quarterly report
AbbVie | 8-K: AbbVie Reports First-Quarter 2024 Financial Results
AbbVie | 8-K: AbbVie Inc. Guidance Including the Impact of Acquired IPR&D and Milestones Expense
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Quaggin Susan E
No Data